BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23579598)

  • 1. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model.
    Shin JY; Sohn J; Park KH
    J Korean Med Sci; 2013 Apr; 28(4):608-13. PubMed ID: 23579598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
    Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
    Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinium myrtillus extract prevents or delays the onset of diabetes--induced blood-retinal barrier breakdown.
    Kim J; Kim CS; Lee YM; Sohn E; Jo K; Kim JS
    Int J Food Sci Nutr; 2015 Mar; 66(2):236-42. PubMed ID: 25582181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
    Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
    Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
    Jiang F; Chen Q; Huang L; Wang Y; Zhang Z; Meng X; Liu Y; Mao C; Zheng F; Zhang J; Yan H
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
    Leal EC; Martins J; Voabil P; Liberal J; Chiavaroli C; Bauer J; Cunha-Vaz J; Ambrósio AF
    Diabetes; 2010 Oct; 59(10):2637-45. PubMed ID: 20627932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumption of Polyphenol-Rich Zingiber Zerumbet Rhizome Extracts Protects against the Breakdown of the Blood-Retinal Barrier and Retinal Inflammation Induced by Diabetes.
    Tzeng TF; Hong TY; Tzeng YC; Liou SS; Liu IM
    Nutrients; 2015 Sep; 7(9):7821-41. PubMed ID: 26389948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
    Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
    Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
    Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
    Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of a coumarin derivative in diabetic rats.
    Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier Breakdown.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Abdelsaid M; Siddiquei MM; Alam K; Van den Eynde K; De Hertogh G; Opdenakker G; Al-Shabrawey M; Van Damme J; Struyf S
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1956-64. PubMed ID: 25711636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.
    Kim J; Kim CS; Lee YM; Jo K; Shin SD; Kim JS
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):691-7. PubMed ID: 22249316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.
    Yu H; Chen L; Jiang J
    Mol Vis; 2010 Nov; 16():2384-94. PubMed ID: 21139695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.
    Kady NM; Liu X; Lydic TA; Syed MH; Navitskaya S; Wang Q; Hammer SS; O'Reilly S; Huang C; Seregin SS; Amalfitano A; Chiodo VA; Boye SL; Hauswirth WW; Antonetti DA; Busik JV
    Diabetes; 2018 Apr; 67(4):769-781. PubMed ID: 29362226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
    Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.